Loading…
Relmada Therapeutics, Inc. is projected to rise to $9.67 by 2027, a +33% move from its current price of $7.26. RLMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.01 | $7.27 | $7.53 | +0.08% |
| May 30 | $6.91 | $7.27 | $7.65 | +0.16% |
| May 31 | $6.83 | $7.28 | $7.75 | +0.24% |
| Jun 1 | $6.77 | $7.28 | $7.83 | +0.32% |
| Jun 2 | $6.72 | $7.29 | $7.91 | +0.40% |
| Jun 3 | $6.67 | $7.29 | $7.97 | +0.48% |
| Jun 4 | $6.63 | $7.30 | $8.04 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.63 | $7.30 | $8.04 | +0.56% |
| Week 2 | $6.41 | $7.34 | $8.41 | +1.13% |
| Week 3 | $6.25 | $7.38 | $8.72 | +1.70% |
| Week 4 | $6.13 | $7.42 | $9.00 | +2.27% |
| Week 5 | $6.02 | $7.47 | $9.26 | +2.84% |
| Week 6 | $5.93 | $7.51 | $9.50 | +3.42% |
| Week 7 | $5.86 | $7.55 | $9.74 | +4.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity.
Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. (RLMD) trades in the Healthcare sector and has a current price of $7.04 with a market cap of $738.43M and a market rank of 2745. The stock’s near-term outlook shows a neutral-to-positive path with a 2026 average price of $7.04 and an ROI of 0, reflecting a Neutral sentiment.
A major floor 51.1% below — a decisive break under it would weaken the trend.
The nearest floor, 12.7% below — buyers have tended to step in here.
The nearest ceiling, 8.3% above — a clean break opens room to run.
A major ceiling 19.5% above — clearing it would confirm fresh momentum.
Key RLMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RLMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.17 | Buy | $7.16 | Buy |
| MA 10 | $7.10 | Buy | $7.16 | Buy |
| MA 20 | $7.29 | Sell | $7.18 | Buy |
| MA 50 | $7.04 | Buy | $6.81 | Buy |
| MA 100 | $5.71 | Buy | $5.94 | Buy |
| MA 200 | $4.14 | Buy | $4.68 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.24 | Neutral |
| Stoch RSI (14) | 79.65 | Neutral |
| CCI (20) | -8.27 | Neutral |
| Williams %R (14) | -20.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -0.82 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 80.00 | Sell |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 53.22 | Neutral |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 7.24 | Buy |
| ADX (14) | 11.84 | Neutral |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is bullish. RSI14 is 50, and the stock trades against a 50-day simple moving average of $6.99 and a 200-day simple moving average of $4.08. Support is indicated at $6.34 and resistance at $7.86, framing a near-term trading band. The 30-day price range spans $5.46 to $9.07, and annualized volatility is about 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.55 | $7.26 | $11.13 | 0% | Neutral | |
| $7.42 | $9.67 | $13.47 | +33% | Bullish | |
| $8.55 | $11.57 | $16.87 | +59% | Bullish | |
| $9.05 | $12.64 | $19.09 | +74% | Bullish | |
| $10.62 | $15.25 | $23.74 | +110% | Bullish | |
| $13.64 | $20.10 | $32.11 | +177% | Bullish | |
| $15.95 | $24.09 | $39.39 | +232% | Bullish | |
| $18.96 | $29.30 | $48.93 | +304% | Bullish | |
| $18.93 | $29.92 | $50.93 | +312% | Bullish | |
| $18.21 | $29.41 | $50.96 | +305% | Bullish | |
| $32.93 | $58.73 | $109.63 | +709% | Bullish | |
| $52.43 | $111.89 | $232.46 | +14.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.55 | $7.26 | $8.61 | +0.00% |
| June 2026 | $6.52 | $7.71 | $9.38 | +6.24% |
| July 2026 | $6.53 | $7.81 | $9.67 | +1.26% |
| August 2026 | $6.52 | $7.87 | $9.88 | +0.80% |
| September 2026 | $6.84 | $8.32 | $10.55 | +5.67% |
| October 2026 | $7.05 | $8.62 | $11.05 | +3.67% |
| November 2026 | $6.88 | $8.48 | $10.96 | -1.71% |
| December 2026 | $6.90 | $8.54 | $11.13 | +0.77% |
Click any year to see its month-by-month RLMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Relmada Therapeutics, Inc.'s 2026 outlook centres on $7.26, within a $3.55 to $11.13 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, RLMD could reach as high as $13.47, with a base case around $9.67 and support toward $7.42 — roughly +33% from $7.26. Buyers look set to stay in control over this stretch.
Expect RLMD to range from $8.55 to $16.87 through 2028. The $11.57 average target implies a +59% move from current prices. That is up +20% on the projected 2027 average. Momentum favours further upside here.
The RLMD price prediction for 2029 points to an average of $12.64 (low $9.05, high $19.09) — a potential gain of +74% on today's $7.26. Buyers look set to stay in control over this stretch.
In 2030, RLMD is projected to trade between $10.62 and $23.74, averaging $15.25 — a potential gain of +110% from today's $7.26. That is up +21% on the projected 2029 average. Momentum favours further upside here.
Relmada Therapeutics, Inc.'s 2031 outlook centres on $20.10, within a $13.64 to $32.11 range. That is up +32% on the projected 2030 average. That marks a +177% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, RLMD could reach as high as $39.39, with a base case around $24.09 and support toward $15.95 — roughly +232% from $7.26. Momentum favours further upside here.
Expect RLMD to range from $18.96 to $48.93 through 2033. The $29.30 average target implies a +304% move from current prices. That is up +22% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The RLMD price prediction for 2034 points to an average of $29.92 (low $18.93, high $50.93) — a potential gain of +312% on today's $7.26. Momentum favours further upside here.
In 2035, RLMD is projected to trade between $18.21 and $50.96, averaging $29.41 — a potential gain of +305% from today's $7.26. That is -2% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Relmada Therapeutics, Inc.'s 2040 outlook centres on $58.73, within a $32.93 to $109.63 range. That is up +100% on the projected 2035 average. That marks a +709% change versus current levels. Momentum favours further upside here.
By 2050, RLMD could reach as high as $232.46, with a base case around $111.89 and support toward $52.43 — roughly +14.4x from $7.26. Buyers look set to stay in control over this stretch.
Investing $1,000 in RLMD today (≈ 137.741047 RLMD) could be worth
$15,412.51
+$14,412.51 (+1441%) by 2050 · US Dollar
Based on the average projected RLMD price of $111.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RLMDwould be worth at today's price.
$1,000 invested in RLMD on May 27, 2025 (≈ 1,510.574017 RLMD) would be worth
$10,966.77
+$9,966.77 (+996.7%) today · 10.97× · US Dollar
Based on a RLMD entry price of $0.662 vs. today's $7.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.17 | $1,012.55 | +1.3% |
| 1 month ago | $7.03 | $1,032.72 | +3.3% |
| 3 months ago | $4.6 | $1,578.26 | +57.8% |
| 6 months ago | $4.51 | $1,609.76 | +61.0% |
| 1 year ago | $0.662 | $10,966.77 | +996.7% |
| All time (5.0y) ago | $32.23 | $225.26 | -77.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RLMD forecast.
Our base-case forecast reaches $15.00 around 2030.
Implied market cap at $15.00: $1.57B
The year-by-year forecast shows a path of rising averages and upside potential, starting with 2026 at an average of $7.04 and an ROI of 0 with Neutral sentiment. In 2027 the average is $9.43 (min $7.18, max $13.29) with ROI 34 and Bullish sentiment, followed by 2028 at $11.22 (min $8.21, max $16.57) with ROI 59.4 and Bullish sentiment, and 2029 at $12.34 (min $8.72, max $18.90) with ROI 75.2 and Bullish sentiment. By 2030 the average reaches $14.61 (min $10.02, max $23.10) with ROI 107.6 and Bullish sentiment, continuing through 2031 at $19.31 (min $12.88, max $31.35) ROI 174.2, 2032 at $23.74 (min $15.42, max $39.49) ROI 237.2, 2033 at $28.81 (min $18.25, max $48.98) ROI 309.2, 2034 at $29.17 (min $18.04, max $50.60) ROI 314.4, and 2035 at $28.86 (min $17.44, max $51.00) ROI 309.9, all with Bullish sentiment.
The forecast extends to 2040 with an average of $57.66 (min $31.28, max $110.06) and ROI 719, and to 2050 with an average of $110.01 (min $49.51, max $234.53) and ROI 1462.7, both carrying Bullish sentiment. These projections illustrate a substantial upside potential over the longer horizon, but they remain estimates and are not guaranteed.
Tap a question to reveal the answer.
The forecast shows an average price of $14.61, a min of $10.02, and a max of $23.10 for 2030, with an ROI of 107.6 and a Bullish sentiment.
The outlook becomes Bullish from 2027 onward, with rising averages and ROIs (e.g., 2027 avg $9.43, ROI 34; 2028 avg $11.22, ROI 59.4; 2030 avg $14.61, ROI 107.6). However, the 2026 forecast is Neutral (avg $7.04, ROI 0), and these are estimates, not guarantees.
Yes. The forecast projects a max of $51.00 in 2035, with higher maxes of $110.06 in 2040 and $234.53 in 2050.
The peak within the provided horizon appears in 2050 with a max of $234.53 and an average of $110.01.
The current price is $7.04 and the market capitalization is $738.43M, with a market rank of 2745.
Relmada Therapeutics, Inc. Community Discussion
0Share your Relmada Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.